Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2860882 | 1.00 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| SCHEMBL441137 | 1.00 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| SCHEMBL16754965 | 0.87 | TAS1R3 (0.55) | SMN1; SMN2TAS1R3TAS1R1KMT2ATDP1 | |
| SCHEMBL557498 | 0.87 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| Stearic Acid SCHEMBL3690236 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3687284 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3696710 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3691439 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3686276 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| SCHEMBL20483598 | 0.81 | USP2 (0.48) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1674447-B1 | Amide mixtures, polyolefin resin compositions, and polyolefin resin molded products | NEW JAPAN CHEM CO LTD (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-7696380-B2 | Such as 1,2,3-propanetricarboxylic acid tris(trans-2-methylcycloheylamide; nucleation | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1674447-A1 | AMIDES, POLYOLEFIN RESIN COMPOSITIONS, AND MOLDINGS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2006-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NAA50, ARG1, RFT1 | USP2 3307/4885SMN1; SMN2 1658/4885EPHX1 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.